AI-generated summary
The authors studied COH-BR1 tumor cells treated with a light-activated drug model (ALA-photodynamic therapy) and found that a nitric oxide donor, added before light, shifted cell death from mainly necrosis toward apoptosis. They report a large rise in caspase-3/7 activation and a protective effect on membranes and ATP levels. The study was conducted in cultured cells, so the findings may not apply directly to living tissue.
- Who or what was studied
- COH-BR1 tumor cells in culture
- Limits stated in the abstract
- The study was conducted in cultured tumor cells rather than in animals or people.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Nitric oxide, Adenosine triphosphate, Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.